CA2845891A1 — Injection device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-03-21 · 13y expired
What this patent protects
According to the invention, an injection device (1) for administering a liquid comprises a pre-filled syringe (3) and a safety mechanism for providing needle safety for an injection needle (3.2) of the pre-filled syringe (3). The pre-filled syringe (3) comprises a barrel (3.1) co…
USPTO Abstract
According to the invention, an injection device (1) for administering a liquid comprises a pre-filled syringe (3) and a safety mechanism for providing needle safety for an injection needle (3.2) of the pre-filled syringe (3). The pre-filled syringe (3) comprises a barrel (3.1) containing the liquid, a stopper (3.5) translatably disposed within the barrel (3.1), the injection needle (3.2) attached to a distal end of the barrel (3.1). The safety mechanism comprises a substantially cylindrical housing (2) adapted to contain the pre-filled syringe (3), a plunger (4) connectable to the stopper (3.5) of the pre-filled syringe (3) and adapted to be translated in a distal direction (D) to expel the liquid through the injection needle (3.2), an energizable biasing means (6) arranged between the housing (2) and the pre-filled syringe (3), wherein the energized biasing means (6) is capable of biasing the pre-filled syringe (3) with respect to the housing (2) in a proximal direction (P) and a retaining mechanism for retaining the pre-filled syringe (3) with respect to the housing (2) in a first retracted position(R1), in an advanced position (A) and in a second retracted position (R2). The injection needle (3.2) is covered by the housing (2) in the first and second retracted positions (R1, R2) and projects distally from the housing (2) in the advanced position (A). The biasing means (6) is arranged in a non-energized state when the pre-filled syringe (3) is in the first retracted position (R1). The biasing means (6) is adapted to be energized upon translation of the pre-filled syringe (3) from the first retracted position (R1) to the advanced position (A) so as to bias the syringe (3) from the advanced position (A) towards the second retracted position (R2).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.